The SIRT1/AMPK signaling pathway is closely related to lipid metabolism, and previous research has suggested that it may contribute to the pathogenesis of NAFLD [33,34]. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.